Chandra Singh in Elyria, Ohio

Home Ohio Elyria

Chandra Singh has Pulmonary Disease as his primary medical specialty. Their primary office is: 125 E Broad St in Elyria, Ohio.

They're a part of the: Respiratory And Sleep Disorders Consultants, Inc medical group which has around 2 members. You can call their office at 440-329-7397 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1975 (around 49 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Chandra V Singh Office Phone and Directions

Chandra Singh
Respiratory And Sleep Disorders Consultants, Inc
125 E Broad St
Elyria, Ohio 44035
440-329-7397

Patient Ratings
Please rate your experience with Chandra Singh below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 440-329-7397

Enter a starting address:

Healthcare Info for Chandra Singh

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS)

Medical School: Sorry, his university is not listed
Graduation Year: 1975
The Primary Medical Specialty for Chandra Singh is listed as: Pulmonary Disease
Approximate Years of Experience: 49
PAC (PECOS ID)#: 8921138173
NPI #: 1639158256
NPI Created On: 01/12/2006
NPI Last Updated Listed as: 06/17/2011
Primary Taxonomy Code: 174400000X
License Number:
35080958S
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Ambetter
MOLINA HEALTHCARE OF OHIO
Humana
CareSource
Summa Insurance Company, Inc.
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: Arabic, English, Indian, Hindi.

Services and Procedures include:

Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
Measurement and graphic recording of total and timed exhaled air capacity
Measurement and graphic recording of total and timed exhaled air capacity
Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
Determination of lung volumes using plethysmography
Determination of lung volumes using plethysmography
Measurement of lung diffusing capacity
Measurement of lung diffusing capacity
Unattended sleep study with recording of heart rate, oxygen, respiratory airflow and effort
Sleep monitoring of patient (6 years or older) in sleep lab
Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 10 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801997949

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802015881

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802197641

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: ANORO ELLIPTA

Open Associated Drug #1: 0173-0869-06

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802695293

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802751327

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 803157237

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: ANORO ELLIPTA

Open Associated Drug #1: 0173-0869-06

Payments Total: $3

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 839144163

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: PAH

Name of Drug #1: TYVASO

Open Associated Drug #1: 66302-206-01

Payments Total: $3

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 839144165

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: PAH

Name of Drug #1: TYVASO

Open Associated Drug #1: 66302-206-01

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 763721250

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: STIOLTO RESPIMAT

Open Associated Drug #1: 0597-0155-61

Drug or Biological: Drug

Product Category #2: RESPIRATORY

Name Of Drug #2:: SPIRIVA RESPIMAT

Associated Drug #2: 0597-0100-61

Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 763721252

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: STIOLTO RESPIMAT

Open Associated Drug #1: 0597-0155-61

Drug or Biological: Drug

Product Category #2: RESPIRATORY

Name Of Drug #2:: SPIRIVA RESPIMAT

Associated Drug #2: 0597-0100-61

Providers in Respiratory And Sleep Disorders Consultants, Inc

1.Sarah Pelfrey

125 E Broad St
Elyria Oh 44035-6429
Respiratory And Sleep Disorders Consultants, Inc
Nurse Practitioner

2.Chandra Singh

125 E Broad St
Elyria Oh 44035-6429
Respiratory And Sleep Disorders Consultants, Inc
Pulmonary Disease

View all 2 members of Respiratory And Sleep Disorders Consultants, Inc medical group